Erratum to: Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus

被引：0
|
作者：
T. M. Reshetnyak
F. A. Cheldieva
M. V. Cherkasova
S. I. Glukhova
A. M. Lila
E. L. Nasonov
机构：
[1] Nasonova Research Institute of Rheumatology,
[2] Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation,undefined
[3] Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University),undefined
来源：
Doklady Biochemistry and Biophysics | 2023年 / 513卷 / 1期
关键词：
D O I：
10.1134/S160767292305006X
中图分类号：
学科分类号：
摘要：
An Erratum to this paper has been published: https://doi.org/10.1134/S160767292305006X
引用
收藏
页码：358 / 358
相关论文
共 50 条
  • [1] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    T. M. Reshetnyak
    F. A. Cheldieva
    M. V. Cherkasova
    S. I. Glukhova
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 219 - 226
  • [2] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, T. M.
    Cheldieva, F. A.
    Cherkasova, M. V.
    Glukhova, S. I.
    Lila, A. M.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 511 (01) : 219 - 226
  • [3] Anti-β2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome
    von Scheven, E
    Glidden, DV
    Elder, ME
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (04): : 414 - 420
  • [4] Immune responses to native β2-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome
    Davies, ML
    Young, SP
    Welsh, K
    Bunce, M
    Wordsworth, BP
    Davies, KA
    Wagenknecht, DR
    Taylor, E
    Gordon, C
    Jobson, S
    Briggs, D
    Bowman, SJ
    RHEUMATOLOGY, 2002, 41 (04) : 395 - 400
  • [5] Antibodies to β2-glycoprotein I:: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus
    Sanfilippo, SS
    Khamashta, MA
    Atsumi, T
    Amengual, O
    Bertolaccini, ML
    D'Cruz, D
    Amft, N
    Swana, GT
    Hughes, GRV
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (11) : 2131 - 2134
  • [6] Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome
    Cousins, Laura
    Pericleous, Charis
    Khamashta, Munther
    Bertolaccini, Maria Laura
    Ioannou, Yiannis
    Giles, Ian
    Rahman, Anisur
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 317 - U444
  • [7] Polymorphism of β2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Gushiken, FC
    Arnett, FC
    Ahn, C
    Thiagarajan, P
    ARTHRITIS AND RHEUMATISM, 1999, 42 (06): : 1189 - 1193
  • [8] IgG anti-β2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus:: Prevalence and diagnostic value for the antiphospholipid syndrome
    Tubach, F
    Hayem, G
    Marchand, JL
    Weber, M
    Palazzo, E
    de Bandt, M
    Roux, S
    Kahn, MF
    Meyer, O
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (06) : 1437 - 1443
  • [9] Anti-β2-glycoprotein I antibodies and systemic lupus erythematosus
    Antolín, J
    Almeida, D
    Amérigo, MJ
    Cantabrana, A
    Roces, A
    Hayeck, M
    MEDICINA CLINICA, 2002, 119 (09): : 331 - 332
  • [10] Heterogeneity of antibodies to β2-glycoprotein 1 from patients with systemic lupus erythematosus
    Cabral, AR
    Cabiedes, J
    Alarcón-Segovia, D
    LUPUS, 2004, 13 (03) : 182 - 187
12345